Parmar Kush
Director, 10% Owner | Director
5 companies
Insider Signal Score
67
StrongTrades Analyzed
12
12M Win Rate
71.4%
Avg 3M Return
+6.2%
Avg 12M Return
+28.2%
Parmar Kush is a Director, 10% Owner at Vor Biopharma Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 2 buys and 18 sells.
Estimated insider holdings value: $127.8M based on current market prices.
Holdings by Company
VORNov 16, 2021
Current Shares4.60M
Value$66.58M
Net Activity+224.8K
Bought: 555.6KSold: 330.7K
TRDANov 14, 2025
Current Shares2.96M
Value$21.01M
Net Activity-102,000
Bought: 250.0KSold: 352.0K
RLYBMar 7, 2023
Current Shares2.38M
Value$37.99M
Net Activity+55.4K
Bought: 615.4KSold: 560.0K
QTTBDec 22, 2020
Current Shares181.4K
Value$2.16M
Net Activity-2,186,157
Bought: 0Sold: 2.19M
ARVNSep 24, 2019
Current Shares1.8K
Value$13.6K
Net Activity0
Bought: 0Sold: 0
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | TRDA Entrada Therapeutics, Inc. | Director, 10% Owner | Sell | 200,000 | $8.80 | $1,760,000.00 | -6.3% | +23.4% | - | |
| Jul 9, 2025 | TRDA Entrada Therapeutics, Inc. | Director, 10% Owner | Sell | 27,000 | $7.50 | $202,554.00 | -0.6% | -22.7% | - | |
| Jul 1, 2025 | TRDA Entrada Therapeutics, Inc. | - | Sell | 125,000 | $6.93 | $866,632.50 | -1.0% | -17.9% | - | |
| Mar 7, 2023 | RLYB Rallybio Corp | Director | Sell | 100,000 | $8.20 | $820,000.00 | -4.0% | +0.8% | -78.0% | |
| Jun 3, 2022 | RLYB Rallybio Corp | Director, 10% Owner | Sell | 150,000 | $12.50 | $1,875,000.00 | -3.9% | +17.9% | -13.6% | |
| May 23, 2022 | RLYB Rallybio Corp | Director, 10% Owner | Sell | 100,000 | $13.00 | $1,300,000.00 | -2.5% | -17.2% | -44.1% | |
| Feb 8, 2022 | RLYB Rallybio Corp | Director | Sell | 210,000 | $13.05 | $2,740,500.00 | -5.0% | -29.0% | -50.5% | |
| Nov 16, 2021 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 330,706 | $15.30 | $5,059,801.80 | -4.9% | -52.4% | -74.0% | |
| Nov 2, 2021 | TRDA Entrada Therapeutics, Inc. | Director, 10% Owner | Buy | 250,000 | $20.00 | $5,000,000.00 | +28.3% | -56.6% | -14.1% | |
| Aug 2, 2021 | RLYB Rallybio Corp | Director | Buy | 615,384 | $13.00 | $7,999,992.00 | +77.8% | +1.1% | -48.4% |
Page 1Next →